Loading stock data…
Omada Health, Inc. (OMDA)
$22.18-0.59 (-2.59%)
Market ClosedLast close Sep 8
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Omada Health, Inc. in the Healthcare sector is trading at $22.18 with a market capitalization of $1.4B. Wall Street consensus targets $28.25 (12 analysts), implying a +27.4% move over the next 12 months. The stock is currently 18% below its 52-week high of $26.91, remaining 30.5% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +27.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $78.05M↑ | $75.85M↑ | $68.03M↑ | $61.37M↑ | $54.96M |
| Gross Profit | $48.69M↓ | $53.66M↑ | $45.07M↑ | $40.31M↑ | $31.90M |
| Operating Income | -$4.78M↓ | $3.28M↑ | -$2.51M↑ | -$4.34M↑ | -$8.40M |
| Net Income | -$2.97M↓ | $5.16M↑ | -$3.18M↑ | -$5.31M↑ | -$9.45M |
Peer Comparison
JNJUNHPFE
Fundamentals
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to ad...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.36B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
33.10
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.70%
Volume
Today's trading volume
1.00M
Recent News
Omada Health (OMDA) Q2 2026 Earnings Call Transcript
Revenue surged 43% to $88 million as margins expanded and guidance rose.
Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy
Omada Health (NASDAQ:OMDA) highlighted record second-quarter revenue and margin performance at the Canaccord Genuity Growth Conference, while outlining its strategy to expand across cardiometabolic conditions, deepen channel partnerships and use GLP-1-related demand to broaden customer relationships
Omada Health (OMDA) Could Be 4% Undervalued As Record Earnings Reset The Debate
Omada Health (OMDA) drew investor attention on 6 August 2026 after reporting record second quarter results, raising full year 2026 guidance, and outlining a planned CEO transition effective 1 January 2027. See our latest analysis for Omada Health. At a latest share price of $23.67, Omada Health has seen a sharp shift in sentiment, with a 1 day share price return of 21.14% and 7 day share price return of 19.30% around the earnings beat and CEO succession news. That sits within a stronger...
Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Omada Health Q2 Earnings Call Highlights
Omada Health (NASDAQ:OMDA) reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve members. The company also announced that President Wei-Li Shao will succeed Co-founder and Chief Executiv